NCT07750054 Testing the Impact of the Parenting Young Children Check-up
| NCT ID | NCT07750054 |
| Status | Recruiting |
| Phase | EARLY_Phase 1 |
| Sponsor | Wayne State University |
| Condition | Behavioral Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 50 participants in total. It began in 2025-11-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed project aims to evaluate the Parenting Young Children Check-up (PYCC) through a randomized clinical trial in a pediatric primary care practice in Detroit that primarily serves low-income families. Fifty parents will be randomized to intervention (n = 25) or control (n = 25) conditions. We will follow up with parents 1 month and 3-months later to test the impact of the program on children's behavioral health/disruptive behavior problems, parenting, and parenting stress and to examine how much parents in the intervention group make use of and report satisfaction with the PYCC program.
Eligibility Criteria
Inclusion Criteria: * Parent of child ages 2-5 years old * Report a score of 9 or higher on the Preschool Pediatric Symptoms Checklist Exclusion Criteria: * Does not speak/read English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07750054 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Behavioral Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07750054 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07750054 currently recruiting?
Yes, NCT07750054 is actively recruiting participants. Contact the research team at Lucy.K.McGoron@wayne.edu for enrollment information.
Where is the NCT07750054 trial being conducted?
This trial is being conducted at Detroit, United States.
Who is sponsoring the NCT07750054 clinical trial?
NCT07750054 is sponsored by Wayne State University. The trial plans to enroll 50 participants.